ctDNA and Recurrence Risk for Adjuvant De-Escalation in HPV-Positive Oropharyngeal Carcinoma: A Secondary Analysis of the DART Phase 3 Randomized Clinical Trial
ctDNA与HPV阳性口咽癌辅助治疗降阶梯治疗的复发风险:DART 3期随机临床试验的二次分析
期刊:Jama Otolaryngology-Head & Neck Surgery
影响因子:5.6
doi:10.1001/jamaoto.2025.0903
Routman, David M; Van Abel, Kathryn M; Price, Katharine A; Moore, Eric J; Patel, Samir H; Hinni, Michael L; Fruth, Briant; Foster, Nathan R; Yin, Linda X; Neben-Wittich, Michelle; Garces, Yolanda I; McGee, Lisa A; Lester, Scott C; Gamez, Mauricio E; Rwigema, Jean-Claude M; Holtzman, Adam L; Price, Daniel L; Janus, Jeffrey R; Kasperbauer, Jan L; Chintakuntlawar, Ashish V; Garcia, Joaquin J; Foote, Robert L; Ma, Daniel J